Globe Life Inc. (NYSE:GL – Get Free Report) CFO Thomas Peter Kalmbach sold 11,790 shares of the company’s stock in a transaction on Friday, May 8th. The shares were sold at an average price of $152.02, for a total value of $1,792,315.80. Following the transaction, the chief financial officer directly owned 40,972 shares in the company, valued at $6,228,563.44. This trade represents a 22.35% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.
Thomas Peter Kalmbach also recently made the following trade(s):
- On Monday, May 11th, Thomas Peter Kalmbach sold 15,637 shares of Globe Life stock. The stock was sold at an average price of $153.65, for a total value of $2,402,625.05.
Globe Life Trading Up 0.6%
NYSE:GL traded up $0.98 on Tuesday, hitting $154.84. 471,678 shares of the stock were exchanged, compared to its average volume of 509,597. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.07 and a current ratio of 0.07. Globe Life Inc. has a 52 week low of $116.73 and a 52 week high of $156.69. The stock has a market capitalization of $12.02 billion, a price-to-earnings ratio of 10.71 and a beta of 0.50. The company’s 50-day moving average price is $145.25 and its 200 day moving average price is $140.63.
Globe Life Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Monday, July 6th will be issued a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Monday, July 6th. Globe Life’s payout ratio is currently 9.13%.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently added to or reduced their stakes in GL. CYBER HORNET ETFs LLC acquired a new position in Globe Life in the second quarter valued at about $28,000. Hilton Head Capital Partners LLC acquired a new position in shares of Globe Life in the 4th quarter valued at approximately $30,000. MUFG Securities EMEA plc bought a new stake in Globe Life during the 2nd quarter worth approximately $31,000. Quent Capital LLC bought a new stake in Globe Life during the 3rd quarter worth approximately $36,000. Finally, Torren Management LLC acquired a new stake in Globe Life during the 4th quarter worth approximately $37,000. 81.61% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
A number of research firms have recently weighed in on GL. Texas Capital raised Globe Life to a “strong-buy” rating in a research note on Wednesday, March 18th. Weiss Ratings downgraded Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a report on Monday, April 27th. Evercore set a $157.00 target price on Globe Life in a research note on Wednesday, February 18th. Truist Financial boosted their target price on Globe Life from $180.00 to $185.00 and gave the stock a “buy” rating in a research report on Friday, April 24th. Finally, Wells Fargo & Company increased their price target on shares of Globe Life from $171.00 to $172.00 and gave the company an “overweight” rating in a research report on Friday, April 10th. Two equities research analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Buy” and a consensus target price of $172.67.
Read Our Latest Stock Analysis on Globe Life
About Globe Life
Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.
The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.
Read More
- Five stocks we like better than Globe Life
- Navy Catalyst Ignites Odysight’s Growth Engine
- AST SpaceMobile Plummets on Galactic Q1 Miss: Can Vertical Integration Save the SpaceX Rival?
- Axon Surged After Earnings and Is Still Down Over 50% From Highs
- The Event That Could Redefine Apple’s Summer Rally
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.
